Two Sigma Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Two Sigma Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$581K	Sell	13,821 -13,464	-49%	-$429K	0.05%	516
2026 Q1	$721K	Buy	27,285 +12,775	+88%	+$374K	0.08%	314
2025 Q4	$420K	Buy	+14,510	New	+$436K	0.06%	467
2024 Q1	–	Sell	-10,448	Closed	-$343K	–	2952
2023 Q4	$343K	Sell	10,448 -4,489	-30%	-$122K	﹤0.01%	1875
2023 Q3	$416K	Buy	+14,937	New	+$488K	﹤0.01%	1673
2022 Q1	–	Sell	-6,424	Closed	-$393K	–	2095
2021 Q4	$393K	Buy	+6,424	New	+$444K	0.02%	663

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Securities's ARKG Position: Q2 2026 in Review

Two Sigma Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 49% in Q2 2026, selling an estimated $429K and leaving 13,821 shares worth $581K. The position accounts for 0.05% of the portfolio, ranked #516.

Two Sigma Securities first reported a position in ARKG in Q4 2021 and has held it in 6 quarters since. The position peaked at $721K in Q1 2026. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Two Sigma Securities held 13,821 shares of ARK Genomic Revolution ETF worth $581K as of Q2 2026.
Two Sigma Securities sold 13,464 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $429K.
ARK Genomic Revolution ETF made up 0.05% of Two Sigma Securities's portfolio in Q2 2026, its #516 holding.
Two Sigma Securities first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 6 quarters since.
Two Sigma Securities's ARK Genomic Revolution ETF position peaked at $721K in Q1 2026.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.